Head and neck cancer surgery is a major surgical oncology intervention designed to excise malignant neoplasms arising from the mucosal surfaces or glandular structures of the head and neck region. As established by the National Comprehensive Cancer Network (NCCN 2024 Guidelines), surgery serves as a primary definitive treatment or as part of a multimodal regimen alongside radiation therapy and chemotherapy. Mechanism of action relies on physical extirpation of neoplastic tissue with adequate surrounding biological margins to prevent local recurrence. Modern head and neck surgical oncology integrates ablative resection with immediate functional and structural reconstruction to optimize patient survival and post-operative quality of life.

Head and neck cancer surgery begins with patient induction under general anesthesia, often involving specialized airway management techniques such as fiberoptic intubation or planned tracheostomy. The head and neck surgeon performs a meticulous wide local excision of the primary lesion, removing the tumor along with a safety envelope of surrounding normal tissue to ensure microscopic clear margins. Frozen section pathology is routinely utilized intraoperatively to analyze margin status immediately. If regional disease is suspected or indicated by staging, a neck dissection is executed to systematically remove fibrofatty tissue and lymph nodes from specified anatomical levels (Levels I through V) of the neck. When large soft tissue or bony defects remain following tumor removal, a reconstructive surgeon executes microvascular free flap transfer, reattaching tiny arteries and veins under an operating microscope to restore facial structure, tongue volume, or jaw integrity. Drains are placed to prevent fluid collection, and incisions are closed in layers.

Surgical resection offers distinct clinical advantages in head and neck oncology. First, it provides immediate physical removal of the primary tumor burden, yielding precise histopathological staging regarding tumor size, depth of invasion, microvascular invasion, and lymph node involvement. According to NCCN 2024 guidelines, primary surgery is particularly advantageous for oral cavity cancers, where surgical excision demonstrates superior local control compared to definitive primary radiation therapy. Second, surgery allows for pathological evaluation of surgical margins, guiding decisions regarding adjuvant radiation or chemoradiotherapy. Third, modern reconstructive techniques restore structural integrity and functional capacity, minimizing long-term tissue changes such as severe late radiation-induced fibrosis or osteoradionecrosis (bone death from radiation exposure).

Recovery from head and neck cancer surgery progresses through acute post-operative, subacute healing, and long-term functional rehabilitation phases. During the initial inpatient stay (typically 5 to 10 days depending on whether reconstructive surgery was performed), clinical focus centers on airway management (via temporary or permanent tracheostomy), monitoring of free flap blood supply, pain control, and enteral nutrition (via nasogastric or gastrostomy feeding tube). Tissue edema generally peaks between post-operative days 3 and 5 before gradually subsiding. Functional rehabilitation begins within the first two weeks, incorporating speech and swallowing therapy to re-establish oral intake and articulation safely. Full soft tissue healing and surgical site maturity occur over 6 to 12 weeks. If adjuvant radiation therapy or chemoradiation is indicated based on surgical pathology, it typically commences within 6 weeks post-surgery to maintain optimal oncologic control (ESTRO-ESMO 2023 guidelines).

Head and neck cancer surgery treats malignant conditions of the upper aerodigestive tract and associated anatomical structures. Primary indications include squamous cell carcinoma (cancer arising from thin, flat mucosal cells) of the oral cavity, tongue, floor of mouth, tonsils, throat, and voice box. It also treats salivary gland neoplasms (tumors of the parotid, submandibular, or minor salivary glands), thyroid carcinoma, sinonasal malignancies (cancers of the nasal cavity and paranasal sinuses), and advanced cutaneous carcinomas of the head and neck. Additionally, it addresses regional lymph node metastasis within the neck through therapeutic neck dissection protocols.

Pre-operative preparation requires a detailed clinical workup, including fiberoptic laryngoscopy, contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) of the head and neck, and whole-body PET-CT scanning for systemic staging. Laboratory testing includes blood counts, coagulation studies, renal function, and nutritional marker profiles. Patients undergo pre-operative anesthesia evaluation and formal speech and swallowing assessments. Dental clearance is mandatory prior to major head and neck resection or planned adjuvant radiation to treat active dental infections and reduce the risk of post-treatment bone complications. Patients must cease smoking and stop alcohol intake at least 2 to 4 weeks prior to surgery to promote wound healing and reduce pulmonary complications. Medically required blood thinners are temporarily held according to perioperative guidelines.

Complications following head and neck cancer surgery are classified by timing and severity. Mild to moderate common side effects include temporary local edema, surgical site pain, altered skin sensation or numbness around incisions, mild shoulder stiffness following neck dissection, and temporary swallowing difficulty. Moderate risks include localized wound infection, seroma or hematoma formation, delayed wound healing, salivary fistula (an abnormal passage leaking saliva onto the neck skin), and temporary weakness of cranial nerves (such as the marginal mandibular branch of the facial nerve or the spinal accessory nerve). Rare but severe complications include airway compromise, acute post-operative bleeding or carotid artery blowout, microvascular reconstructive flap failure due to arterial or venous thrombosis, deep vein thrombosis or pulmonary embolism, pneumonia, and permanent swallowing dysfunction requiring long-term gastrostomy tube dependence.

The head and neck cancer surgery patient journey begins with a comprehensive pre-operative evaluation, including high-resolution imaging, biopsy confirmation, and multidisciplinary tumor board review. Patients undergo pre-rehabilitation to optimize nutritional status, airway safety, and swallowing function. On the day of surgery, general anesthesia is administered, followed by tumor resection, potential neck dissection for lymph node clearance, and microvascular reconstructive tissue transfer if required. Immediate post-operative care takes place in an intensive care or specialized step-down unit to monitor airway stability, graft viability, and neurovascular status. Over subsequent weeks, the patient transitions from inpatient recovery to structured outpatient rehabilitation, encompassing speech and language therapy, physical therapy for shoulder mobility, and longitudinal oncologic surveillance.